Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Johnson & Johnson (JNJ)

141.14 0.55 (0.39%)

12-11 16:01

Open:

140.1

Pre. Close:

140.59

High:

141.17

Low:

139.83

Volume:

4,358,620

Market Cap:

379175M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

141.47 - 141.88

141.88 - 142.4

Low:

138.39 - 138.87

138.87 - 139.48

Close:

140.21 - 140.97

140.97 - 141.93

Technical analysis  (as of: 2017-12-11 4:48:49 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 165.81     One year: 193.67

Support:

Support1: 138.65    Support2: 136.60

Resistance:

Resistance1: 141.96    Resistance2: 165.81

Pivot:

139.35

Moving Averages:

MA(5): 140.49     MA(20): 139.28

MA(100): 135.61     MA(250): 128.48

MACD:

MACD(12,26): 0.50     Signal(12,26,9): 0.35

%K %D:

%K(14,3): 74.25     %D(3): 72.61

RSI:

RSI(14): 59.17

52-Week:

High: 144.35  Low: 110.76  Change(%): 21.8

Average Vol(K):

3-Month: 517544  10-Days 574728

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
JNJ has closed below upper band by 11.3%. Bollinger Bands are 23.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 05 Dec 2017 18:55:17 GMT
The Outlook For Johnson & Johnson's Immunology Drug Business

Sat, 09 Dec 2017 15:33:45 GMT
Dividend stats on Johnson & Johnson

Thu, 07 Dec 2017 21:22:30 GMT
Johnson & Johnson (JNJ) Management Presents at Citi Global Healthcare Conference

Mon, 11 Dec 2017 18:33:45 GMT
One Put, One Call Option To Know About for Johnson & Johnson

Mon, 04 Dec 2017 11:15:00 GMT
Will 2018 Be Johnson & Johnson's Best Year Yet?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

2690.00

Shares Float (M)

2690.00

% Held by Insiders

0.05

% Held by Institutions

67.79

Shares Short (K)

13210

Shares Short Prior Month (K)

13610

Stock Financials

EPS

5.750

EPS Est. Current Year

7.280

EPS Est. Next Year

7.850

EPS Est. Next Quarter

1.990

Forward EPS

7.859

Book Value (p.s.)

27.550

PEG Ratio

2.74

Profit Margin

21.28

Operating Margin

28.03

Return on Assets (ttm)

8.8

Return on Equity (ttm)

21.6

Qtrly Rev. Growth

10.3

Gross Profit (p.s.)

18.662

Sales Per Share

EBITDA (p.s.)

9.543

Qtrly Earnings Growth

-11.90

Operating Cash Flow (M)

21600.00

Levered Free Cash Flow (M)

15640.00

atoplab.com

Valuation

P/E

24.55

P/E Growth Ratio

P/BV

5.12

P/S

13781001216.00

P/CF

17.58

Dividend Yield

0.02

Dividends & Splits

Dividend

3.280

Dividend Pay Date

2017-12-12

Ex-Dividend Date

2017-11-27

Forward Dividend

3.360

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.